Table of Contents
ISRN Dermatology
Volume 2011, Article ID 346754, 4 pages
http://dx.doi.org/10.5402/2011/346754
Case Report

Photodynamic Therapy for Basal Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa

1Department of Dermatology, The Royal Melbourne Hospital, Grattan Street, Parkville, VIC 3050, Australia
2Department of Medicine, The University of Melbourne, Parkville, VIC 3050, Australia
3Department of Dermatology, St. Vincent's Hospital, Fitzroy, VIC 3065, Australia
4Skin and Cancer Foundation, 80 Drummond Street, Carlton, VIC 3053, Australia

Received 19 February 2011; Accepted 24 March 2011

Academic Editor: C. Ferrándiz

Copyright © 2011 Myn Wee Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Champion, J. L. Burton, D. A. Burns, and S. M. Breathnach, Rook's Textbook of Dermatology, vol. 3, Blackwell Science, Oxford, UK, 6th edition, 1998.
  2. R. Varki, S. Sadowski, J. Uitto, and E. Pfendner, “Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes,” Journal of Medical Genetics, vol. 44, pp. 181–192, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. V. Wessagowit, R. Mallipeddi, J. A. McGrath, and A. P. South, “Altered expression of L-arginine metabolism pathway genes in chronic wounds in recessive dystrophic epidermolysis bullosa,” Clinical and Experimental Dermatology, vol. 29, no. 6, pp. 664–668, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. R. Mallipeddi, “Epidermolysis bullosa and cancer,” Clinical and Experimental Dermatology, vol. 27, no. 8, pp. 616–623, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. O. D. Fine, L. B. Johnson, M. Weiner, K. P. Li, and C. Suchindran, “Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986–2006,” Journal of the American Academy of Dermatology, vol. 60, no. 2, pp. 203–211, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. Reifenberger, M. Wolter, C. B. Knobbe et al., “Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas,” British Journal of Dermatology, vol. 152, no. 1, pp. 43–51, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. J. T. Trent and R. S. Kirsner, “Wounds and malignancy,” Advances in Skin & Wound Care, vol. 16, no. 1, pp. 31–34, 2003. View at Google Scholar · View at Scopus
  8. C. A. Morton, K. E. McKenna, and L. E. Rhodes, “Guidelines for topical photodynamic therapy: update,” British Journal of Dermatology, vol. 159, no. 6, pp. 1245–1266, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. S. Souza, L. B. A. Felício, M. V. Bentley et al., “Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa,” British Journal of Dermatology, vol. 153, no. 3, pp. 672–674, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus